PSORIASIS TREATMENT WITH BIOLOGICS: BEYOND TUMOR NECROSIS FACTOR α INIHIBITORS – THE PRESENT AND THE FUTURE

Detalhes bibliográficos
Autor(a) principal: Carvalho, Sandrina
Data de Publicação: 2013
Outros Autores: Torres, Tiago, Selores, Manuela
Tipo de documento: Artigo
Idioma: por
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
DOI: 10.29021/spdv.70.3.5
Texto Completo: https://doi.org/10.29021/spdv.70.3.5
Resumo: Psoriasis is a chronic systemic T-cell-mediated inflammatory disease with high morbidity. Psoriasis’s investigation has been intense, improving knowledge on physiopathology and leading to new biologic therapies for moderate and severe psoriasis’s treatment. This review will focus the present and the future of anti-cytokine therapies, beside the class of tumor necrosis factor-α (TNF-α) blockers.KEYWORDS – Antibodies, Monoclonal; Biological agents; Dermatologic agents; Psoriasis.
id RCAP_2ee962414da18effaa0a52141c3a0d97
oai_identifier_str oai:ojs.revista.spdv.com.pt:article/5
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling PSORIASIS TREATMENT WITH BIOLOGICS: BEYOND TUMOR NECROSIS FACTOR α INIHIBITORS – THE PRESENT AND THE FUTURETRATAMENTO DA PSORÍASE COM AGENTES BIOLÓGICOS: PARA ALÉM DOS INIBIDORES DO TNF α – O PRESENTE E O FUTUROPsoriasis is a chronic systemic T-cell-mediated inflammatory disease with high morbidity. Psoriasis’s investigation has been intense, improving knowledge on physiopathology and leading to new biologic therapies for moderate and severe psoriasis’s treatment. This review will focus the present and the future of anti-cytokine therapies, beside the class of tumor necrosis factor-α (TNF-α) blockers.KEYWORDS – Antibodies, Monoclonal; Biological agents; Dermatologic agents; Psoriasis.A psoríase é uma doença inflamatória crónica multissistémica, mediada por células T, com elevado grau de morbilidade. A investigação na área da psoríase tem sido intensa, resultando num conhecimento mais porme- norizado da sua patogenia, e consequente desenvolvimento de novas terapêuticas biológicas. Esta revisão focará o presente e o futuro dos agentes biológicos moduladores de citoquinas que não pertencem à classe dos inibidores do factor de necrose tumoral-α (TNF-α).PALAVRAS-CHAVE – Anticorpos monoclonais; Psoríase; Agentes biológicos; Ustekinumab.Sociedade Portuguesa de Dermatologia e Venereologia2013-01-13T00:00:00Zjournal articleinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://doi.org/10.29021/spdv.70.3.5oai:ojs.revista.spdv.com.pt:article/5Journal of the Portuguese Society of Dermatology and Venereology; Vol 70 No 3 (2012): Julho - Setembro; 299Revista da Sociedade Portuguesa de Dermatologia e Venereologia; v. 70 n. 3 (2012): Julho - Setembro; 2992182-24092182-2395reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPporhttps://revista.spdv.com.pt/index.php/spdv/article/view/5https://doi.org/10.29021/spdv.70.3.5https://revista.spdv.com.pt/index.php/spdv/article/view/5/5Carvalho, SandrinaTorres, TiagoSelores, Manuelainfo:eu-repo/semantics/openAccess2022-10-06T12:34:34Zoai:ojs.revista.spdv.com.pt:article/5Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T16:10:36.731770Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv PSORIASIS TREATMENT WITH BIOLOGICS: BEYOND TUMOR NECROSIS FACTOR α INIHIBITORS – THE PRESENT AND THE FUTURE
TRATAMENTO DA PSORÍASE COM AGENTES BIOLÓGICOS: PARA ALÉM DOS INIBIDORES DO TNF α – O PRESENTE E O FUTURO
title PSORIASIS TREATMENT WITH BIOLOGICS: BEYOND TUMOR NECROSIS FACTOR α INIHIBITORS – THE PRESENT AND THE FUTURE
spellingShingle PSORIASIS TREATMENT WITH BIOLOGICS: BEYOND TUMOR NECROSIS FACTOR α INIHIBITORS – THE PRESENT AND THE FUTURE
PSORIASIS TREATMENT WITH BIOLOGICS: BEYOND TUMOR NECROSIS FACTOR α INIHIBITORS – THE PRESENT AND THE FUTURE
Carvalho, Sandrina
Carvalho, Sandrina
title_short PSORIASIS TREATMENT WITH BIOLOGICS: BEYOND TUMOR NECROSIS FACTOR α INIHIBITORS – THE PRESENT AND THE FUTURE
title_full PSORIASIS TREATMENT WITH BIOLOGICS: BEYOND TUMOR NECROSIS FACTOR α INIHIBITORS – THE PRESENT AND THE FUTURE
title_fullStr PSORIASIS TREATMENT WITH BIOLOGICS: BEYOND TUMOR NECROSIS FACTOR α INIHIBITORS – THE PRESENT AND THE FUTURE
PSORIASIS TREATMENT WITH BIOLOGICS: BEYOND TUMOR NECROSIS FACTOR α INIHIBITORS – THE PRESENT AND THE FUTURE
title_full_unstemmed PSORIASIS TREATMENT WITH BIOLOGICS: BEYOND TUMOR NECROSIS FACTOR α INIHIBITORS – THE PRESENT AND THE FUTURE
PSORIASIS TREATMENT WITH BIOLOGICS: BEYOND TUMOR NECROSIS FACTOR α INIHIBITORS – THE PRESENT AND THE FUTURE
title_sort PSORIASIS TREATMENT WITH BIOLOGICS: BEYOND TUMOR NECROSIS FACTOR α INIHIBITORS – THE PRESENT AND THE FUTURE
author Carvalho, Sandrina
author_facet Carvalho, Sandrina
Carvalho, Sandrina
Torres, Tiago
Selores, Manuela
Torres, Tiago
Selores, Manuela
author_role author
author2 Torres, Tiago
Selores, Manuela
author2_role author
author
dc.contributor.author.fl_str_mv Carvalho, Sandrina
Torres, Tiago
Selores, Manuela
description Psoriasis is a chronic systemic T-cell-mediated inflammatory disease with high morbidity. Psoriasis’s investigation has been intense, improving knowledge on physiopathology and leading to new biologic therapies for moderate and severe psoriasis’s treatment. This review will focus the present and the future of anti-cytokine therapies, beside the class of tumor necrosis factor-α (TNF-α) blockers.KEYWORDS – Antibodies, Monoclonal; Biological agents; Dermatologic agents; Psoriasis.
publishDate 2013
dc.date.none.fl_str_mv 2013-01-13T00:00:00Z
dc.type.driver.fl_str_mv journal article
info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://doi.org/10.29021/spdv.70.3.5
oai:ojs.revista.spdv.com.pt:article/5
url https://doi.org/10.29021/spdv.70.3.5
identifier_str_mv oai:ojs.revista.spdv.com.pt:article/5
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://revista.spdv.com.pt/index.php/spdv/article/view/5
https://doi.org/10.29021/spdv.70.3.5
https://revista.spdv.com.pt/index.php/spdv/article/view/5/5
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Sociedade Portuguesa de Dermatologia e Venereologia
publisher.none.fl_str_mv Sociedade Portuguesa de Dermatologia e Venereologia
dc.source.none.fl_str_mv Journal of the Portuguese Society of Dermatology and Venereology; Vol 70 No 3 (2012): Julho - Setembro; 299
Revista da Sociedade Portuguesa de Dermatologia e Venereologia; v. 70 n. 3 (2012): Julho - Setembro; 299
2182-2409
2182-2395
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1822183363804397568
dc.identifier.doi.none.fl_str_mv 10.29021/spdv.70.3.5

Registros relacionados